GLI and Others Nominate Julius M. Wilder MD, PhD to National Diabetes and Digestive and Kidney Diseases Advisory Council (NDDKAC)

GLI Urges Passage of the Treat and Reduce Obesity Act (TROA)

Global Liver Institute recognizes the relationship between nonalcoholic fatty liver disease (NAFLD), its advanced form, nonalcoholic steatohepatitis (NASH), and obesity. Preventing liver disease is directly associated with treating and reducing obesity. Worldwide, NASH affects more than 148 million people and continues to become more prevalent each year.

read more